Skip to content
Blogs
FEATURED | May 1, 2025

Why I’m Getting Naked for Skin Health 

Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...

3 Minute Read
Melanoma News |
January 13, 2011

Pharmawire Examines New FDA Guidelines on Combina...

Pharmawire recently featured this article on the U.S. Food and Drug Administration’s (FDA) newly released draft guidelines for the co-development of combination thera...

1 Minute Read
Blogs |
December 27, 2010

The New York Times and Amy Harmon Cover Melanoma f...

The New York Times' latest installment in their ongoing coverage of melanoma focuses on the role that patients have in solving the problem of tumor resistance and spotl...

1 Minute Read
Melanoma News |
November 23, 2010

MRF Meets with FDA on State of Melanoma Drug Devel...

The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Direc...

2 Minute Read
Blogs |
November 9, 2010

In Memory of Jenna Bockmiller

Over the weekend the melanoma community lost a true fighter.  Jenna Bockmiller of California died at the age of 20, after a 6-year battle with melanoma. Her tenacious ...

2 Minute Read
Blogs |
November 8, 2010

5 Questions That May Help You Dodge Cancer

WASHINGTON— With growing financial and time pressures in medical care, the era of the leisurely doctor’s visit is largely gone.  As visits become increasin...

7 Minute Read
Blogs |
November 5, 2010

Promising Phase II Results for New Drug to Treat A...

Roche announced results from a Phase II clinical study of RG7204 (PLX4032), an inhibitor targeting the BRAF protein that is found in half of metastatic melanoma tumors.&nbs...

1 Minute Read
Melanoma News |
November 3, 2010

FDA Extends Deadline for Decision on Ipilimumab

The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab. ...

1 Minute Read
Blogs |
November 2, 2010

Melanoma Research Gets Boost from Washington, D.C....

WASHINGTON, D.C.— For years, treatment options for patients with advanced melanoma have been bleak, with survival averaging around one year after diagnosis.  But...

5 Minute Read
Blogs |
October 20, 2010

MRF to Young Adults: Debunk Melanoma Myths To Inc...

WASHINGTON, D.C.—Melanoma’s role as the number one form of cancer in young adults may be fueled by pervasive myths and misunderstandings about risk factors, and...

6 Minute Read
Blogs |
October 7, 2010

Respected Producer/Writer Succumbs to Melanoma

The Melanoma Research Foundation (MRF) is deeply saddened to learn of the loss of famed Hollywood producer and writer Stephen J. Cannell, who recently passed away from...

1 Minute Read
Blogs |
September 27, 2010

The New York Times Publishes MRF Letter to the Edi...

The MRF submitted a letter to the editor in response to a recent article in The New York Times, “When Testing a Drug Means Withholding It.”  The article fo...

1 Minute Read
Blogs |
September 13, 2010

MRF Scientific Advisor Examines Indoor Tanning

The New England Journal of Medicine recently published an article focused on indoor tanning, written by scientific advisor to the MRF and chair of the department of dermato...

1 Minute Read

Jul 15, 2025 ET

Ask The Expert: Focusing on the Liver: Treatment Approaches in Metastatic Ocular Melanoma

Jul 20, 2025 ET

Miles for Melanoma Chicago, IL

Jul 22, 2025 ET

Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community

Aug 03, 2025 ET

Miles for Melanoma Cleveland, OH

Aug 10, 2025 ET

Miles for Melanoma Twin Cities, MN

Aug 23, 2025 ET

Miles for Melanoma Philadelphia, PA

Sep 13, 2025 ET

Miles for Melanoma New York City, NY

Explore Events